The Studies of Prognostic Factors and the Genetic Polymorphism of Methylenetetrahydrofolate Reductase C667T in Thymic Epithelial Tumors

The Studies of Prognostic Factors and the Genetic Polymorphism of Methylenetetrahydrofolate Reductase C667T in Thymic Epithelial Tumors

ObjectiveTo describe the clinical features of a cohort of patients with thymic epithelial tumors (TETs) and to analyze their prognostic factors. In particular, we investigated the correlation between the genetic polymorphism of methylenetetrahydrofolate reductase (MTHFR) C667T and the incidence of T...

Full description

Bibliographic Details
Main Authors: Miaolong Yan, Jiayuan Wu, Min Xue, Juanfen Mo, Li Zheng, Jun Zhang, Zhenzhen Gao, Yi Bao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
thymic epithelial tumors
Masaoka–Koga Stage
8th UICC/AJCC TNM staging
MTHFR polymorphism
methylation
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.847957/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.847957/full

Similar Items